284 related articles for article (PubMed ID: 23189380)
21. Excessive masturbation and hypersexual behavior associated with methylphenidate.
Bilgiç A; Gürkan K; Türkoğlu S
J Am Acad Child Adolesc Psychiatry; 2007 Jul; 46(7):789-90. PubMed ID: 17581441
[No Abstract] [Full Text] [Related]
22. Long-acting methylphenidate reduces collision rates of young adult drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Davis M; Mikami AY; Singh H; Merkel RL; Burket R
J Clin Psychopharmacol; 2012 Apr; 32(2):225-30. PubMed ID: 22367664
[TBL] [Abstract][Full Text] [Related]
23. Safe and effective methylphenidate therapy in a pediatric patient with glaucoma.
Lewis H; Lewis J
Atten Defic Hyperact Disord; 2012 Mar; 4(1):37-9. PubMed ID: 22311620
[TBL] [Abstract][Full Text] [Related]
24. Transdermal methylphenidate (Daytrana) for ADHD.
Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850
[No Abstract] [Full Text] [Related]
25. A case report of Concerta misuse in a patient with comorbid substance use disorder and attention deficit hyperactivity disorder.
Rizkallah E; Legault L; Pampoulova T; Lévesque S; Bélanger M; Stavro K; Chiasson JP; Potvin S
Am J Addict; 2011; 20(5):478-9. PubMed ID: 21838849
[No Abstract] [Full Text] [Related]
26. Methylphenidate: pulmonary hypertension and heart valve disease.
Prescrire Int; 2015 Jun; 24(161):154-5. PubMed ID: 26436168
[TBL] [Abstract][Full Text] [Related]
27. Status epilepticus associated with the administration of long-acting methylphenidate in a 7-year-old girl.
Goetz M; Surman CB; Mlynarova E; Krsek P
J Clin Psychopharmacol; 2012 Apr; 32(2):300-2. PubMed ID: 22388167
[No Abstract] [Full Text] [Related]
28. [Life-threatening heart failure caused by ADHD medication. Five case reports described].
Wikström G; Kvidal P; Hagström E
Lakartidningen; 2012 Nov 7-13; 109(45):2016-8. PubMed ID: 23240309
[No Abstract] [Full Text] [Related]
29. [Methylphenidate].
Tagaya H; Murayama N; Fukase Y
Nihon Rinsho; 2015 Sep; 73(9):1511-5. PubMed ID: 26394513
[TBL] [Abstract][Full Text] [Related]
30. [Apropos the National Board and Welfare's report on ADDH: some views on the treatment with central nervous system stimulants].
Zetterström R
Lakartidningen; 2002 Aug; 99(35):3435-6. PubMed ID: 12362770
[No Abstract] [Full Text] [Related]
31. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
[TBL] [Abstract][Full Text] [Related]
32. Methylphenidate-associated enuresis in attention deficit hyperactivity disorder.
Ghanizadeh A
J Pediatr Urol; 2008 Aug; 4(4):306-7. PubMed ID: 18644535
[TBL] [Abstract][Full Text] [Related]
33. Methylphenidate euphoria.
Corrigall R; Ford T
J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1421. PubMed ID: 8936903
[No Abstract] [Full Text] [Related]
34. An unlikely vice: Ritalin.
Vishio J
Adv Nurse Pract; 2001 Feb; 9(2):60. PubMed ID: 12416056
[No Abstract] [Full Text] [Related]
35. Transdermal methylphenidate system: old wine in a new bottle.
Bukstein OG
Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):661-5. PubMed ID: 19442029
[TBL] [Abstract][Full Text] [Related]
36. Acute generalized exanthematous pustulosis induced by methylphenidate: a new adverse effect.
Heinzerling LM; Pichler W; Anliker MD
Arch Dermatol; 2011 Jul; 147(7):872-3. PubMed ID: 21768498
[No Abstract] [Full Text] [Related]
37. Pharmacological management of treatment-induced insomnia in ADHD.
Kratochvil CJ; Lake M; Pliszka SR; Walkup JT
J Am Acad Child Adolesc Psychiatry; 2005 May; 44(5):499-501. PubMed ID: 15843773
[No Abstract] [Full Text] [Related]
38. Acute myocardial infarction related to methylphenidate for adult attention deficit disorder.
Thompson J; Thompson JR
J Emerg Med; 2010 Jan; 38(1):18-21. PubMed ID: 18024065
[TBL] [Abstract][Full Text] [Related]
39. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
Faraone SV; Wilens TE
J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
[TBL] [Abstract][Full Text] [Related]
40. ADHD treatment and the risk of substance abuse.
Sircy RA; Stojanoski A
Nurse Pract; 2008 Apr; 33(4):33-6. PubMed ID: 18388552
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
